Arrevus' Unattributed Round

Arrevus raised a round of funding on May 25, 2017.

Arrevus is focusing its drug development efforts on those diseases for which antibiotic resistance has important clinical implications and for which few therapies exist. These efforts are dedicated t…

Articles about Arrevus' Unattributed Round: